News

Seven Things to Know About ProPublica’s Investigation of the FDA’s Secret Gamble on Generic Drugs
ProPublica spent 14 months investigating the FDA’s oversight of foreign drugmakers that send medications to the U.S. These ...
ProPublica Sued the FDA for Withholding Records About the Safety of Generic Drugs
The agency declined to quickly release documents that would identify drugs made at some of the most troubled foreign ...
Gilead’s twice-a-year HIV prevention shot wins regulatory approval in US
Gilead Sciences Inc said it won United States approval from Food and Drug Administration regulators for a drug to prevent HIV that only has to be given twice a year. That makes it a convenient new way ...
FDA Greenlights Twice-A-Year HIV Prevention Drug
Yeztugo, a twice-a-year antiviral shot to prevent HIV, was approved by the Food and Drug Administration on Wednesday, marking ...
Drug pricing reform talks with US government lack clarity, industry executives say
Talks with the Trump administration about lowering U.S. drug prices have so far not provided clarity on when and how reduced prices will be implemented, top executives from Eli Lilly and Merck said at ...
Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments
U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth up to $25 billion.
No Drug Price Pledges by Pfizer, Others in Talks With US Government, Pfizer CEO Says
(Reuters) -Pfizer and other drug companies have met with the Trump administration to discuss most-favored-nation pricing but no commitments have been made, Chief Executive Albert Bourla said on Monday ...